drugset / Trial / NCT05793996
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
Phase 4
Recruiting
100 enrolled
Tomsk National Research Medical Center of the Russian Academy of Sciences
RandomizedParallel-groupDouble-blindTreatment
Summary
Observational cohort randomized controlled study to study the influence of correction of ID by intravenous injection of ferric carboxymaltose (Ferinject®) on quality of life indicators, functional status in a cohort of patients with HFpEF.
Timeline
- Start
- 2023-04-28
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferric carboxymaltose | Other / unclassified | — | Intravenous |